Fass RJ - Search Results

1

Isolation of fluconazole-resistant Candida albicans from human immunodeficiency virus-negative patients never treated with azoles.

Goff DA, Koletar SL, Buesching WJ, Barnishan J, Fass RJ. Goff DA, et al. Among authors: fass rj. Clin Infect Dis. 1995 Jan;20(1):77-83. doi: 10.1093/clinids/20.1.77. Clin Infect Dis. 1995. PMID: 7727675

2

Comparison of oral fluconazole and clotrimazole troches as treatment for oral candidiasis in patients infected with human immunodeficiency virus.

Koletar SL, Russell JA, Fass RJ, Plouffe JF. Koletar SL, et al. Among authors: fass rj. Antimicrob Agents Chemother. 1990 Nov;34(11):2267-8. doi: 10.1128/AAC.34.11.2267. Antimicrob Agents Chemother. 1990. PMID: 2073120 Free PMC article. Clinical Trial.

3

Penicillinase production and in vitro susceptibilities of Staphylococcus lugdunensis.

Herchline TE, Barnishan J, Ayers LW, Fass RJ. Herchline TE, et al. Among authors: fass rj. Antimicrob Agents Chemother. 1990 Dec;34(12):2434-5. doi: 10.1128/AAC.34.12.2434. Antimicrob Agents Chemother. 1990. PMID: 2088201 Free PMC article.

4

Emergence of bacterial resistance to imipenem and ciprofloxacin in a university hospital.

Fass RJ, Barnishan J, Ayers LW. Fass RJ, et al. J Antimicrob Chemother. 1995 Aug;36(2):343-53. doi: 10.1093/jac/36.2.343. J Antimicrob Chemother. 1995. PMID: 8522464

5

In vitro activities of quinolones, beta-lactams, tobramycin, and trimethoprim-sulfamethoxazole against nonfermentative gram-negative bacilli.

Fass RJ, Barnishan J, Solomon MC, Ayers LW. Fass RJ, et al. Antimicrob Agents Chemother. 1996 Jun;40(6):1412-8. doi: 10.1128/AAC.40.6.1412. Antimicrob Agents Chemother. 1996. PMID: 8726011 Free PMC article.

6

The utility of non-beta-lactam antimicrobial MICs as markers to distinguish oxacillin-resistant from oxacillin-susceptible strains of Staphylococcus epidermidis.

Fass RJ, Barnishan J, Ayers LW. Fass RJ, et al. Diagn Microbiol Infect Dis. 1996 Sep;26(1):43-5. doi: 10.1016/s0732-8893(96)00163-0. Diagn Microbiol Infect Dis. 1996. PMID: 8950529

7

Comparison of antimicrobial in vitro activities against Streptococcus pneumoniae independent of MIC susceptibility breakpoints using MIC frequency distribution curves, scattergrams and linear regression analyses.

Fass RJ, Barnishan J. Fass RJ, et al. J Antimicrob Chemother. 2001 Nov;48(5):609-15. doi: 10.1093/jac/48.5.609. J Antimicrob Chemother. 2001. PMID: 11679549

8

A prospective study of discontinuing primary and secondary Pneumocystis carinii pneumonia prophylaxis after CD4 cell count increase to > 200 x 106 /l.

Koletar SL, Heald AE, Finkelstein D, Hafner R, Currier JS, McCutchan JA, Vallee M, Torriani FJ, Powderly WG, Fass RJ, Murphy RL; ACTG 888 Study Team. Koletar SL, et al. Among authors: fass rj. AIDS. 2001 Aug 17;15(12):1509-15. doi: 10.1097/00002030-200108170-00008. AIDS. 2001. PMID: 11504983 Clinical Trial.

9

In vitro susceptibilities of nonfermentative gram-negative bacilli other than Pseudomonas aeruginosa to 32 antimicrobial agents.

Fass RJ, Barnishan J. Fass RJ, et al. Rev Infect Dis. 1980 Nov-Dec;2(6):841-53. doi: 10.1093/clinids/2.6.841. Rev Infect Dis. 1980. PMID: 7012987 Review.

10

Candida infections in the surgical intensive care unit.

Fass RJ, Goff DA, Sierawski SJ. Fass RJ, et al. J Antimicrob Chemother. 1996 Nov;38(5):915-6. doi: 10.1093/jac/38.5.915. J Antimicrob Chemother. 1996. PMID: 8961068 No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

137 results

Search Page

Filters